Target intelligence / Profile preview

Gram-negative bacterial outer membrane lipopolysaccharide core (LPS core)

Target
LPS core
Molecular classification
Bacterial cell wall component, Glycolipid, Endotoxin
01

Overview

The Gram-negative bacterial outer membrane lipopolysaccharide (LPS) core is a complex oligosaccharide region that links the membrane-anchored lipid A to the peripheral O-antigen [1]. It is structurally divided into an inner core, characterized by unique sugars like 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo), and an outer core composed of more common hexoses [2]. This region is vital for the structural integrity of the bacterial outer membrane and acts as a selective permeability barrier against toxic hydrophobic molecules and host immune factors [2]. Because the inner core is highly conserved across many pathogenic Gram-negative species, it represents a significant target for the development of broad-spectrum antibiotics and neutralizing antibodies [5]. Therapeutic agents such as polymyxins bind to the LPS core and lipid A, displacing stabilizing divalent cations and leading to membrane disruption and bacterial cell death [3]. Despite its potential, targeting the LPS core in clinical settings like sepsis has proven challenging due to the complex inflammatory cascades triggered by endotoxin release [5]. Sources: [1] Raetz & Whitfield (2002) Ann. Rev. Biochem.; [2] Bertani & Ruiz (2018) EcoSal Plus; [3] PubChem (2024) Polymyxin B; [4] NIH/StatPearls (2023) Gram-Negative Bacteria; [5] Opal (2010) Int. J. Med. Microbiol.

Other names
Core oligosaccharideEndotoxin coreLipopolysaccharide inner and outer coreLPS core region
02

Mechanism of action

Displacement of divalent cations (Mg2+ and Ca2+) from the LPS core and lipid A, leading to outer membrane destabilization, increased permeability, and eventual cell lysis [3].

03

Biological functions

Outer membrane stabilizationPermeability barrierProtection against host defense mechanismsResistance to hydrophobic antibiotics
04

Disease associations

Gram-negative bacterial infectionSepsisSeptic shockEndotoxemia
05

Safety considerations

NephrotoxicityNeurotoxicityJarisch-Herxheimer reactionSystemic inflammatory response syndrome (SIRS) due to rapid endotoxin release
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

Endotoxin Activity Assay (EAA)Limulus Amebocyte Lysate (LAL) testProcalcitoninC-reactive protein

Beyond the preview

Go deeper on Gram-negative bacterial outer membrane lipopolysaccharide core (LPS core).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial outer membrane lipopolysaccharide core (LPS core).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call